Showing 1 - 18 results of 18 for search 'Galatea Kallergi', query time: 0.07s
Refine Results
-
1
Evaluation of Isolation Methods for Circulating Tumor Cells (CTCs) by Galatea Kallergi, Eleni Politaki, Saad Alkahtani, Christos Stournaras, Vassilis Georgoulias
Published 2016-11-01
Article -
2
-
3
-
4
-
5
-
6
-
7
Comprehensive liquid biopsy analysis as a tool for the early detection of minimal residual disease in breast cancer by Dimitra Stergiopoulou, Athina Markou, Areti Strati, Martha Zavridou, Eleni Tzanikou, Sophia Mastoraki, Galatea Kallergi, Vassilis Georgoulias, Evi Lianidou
Published 2023-01-01
Article -
8
CD8 PD-1 T-cells and PD-L1 circulating tumor cells in chemotherapy-naïve non-small cell lung cancer: towards their clinical relevance? by Athanasios Kotsakis, Galatea Kallergi, Despoina Aggouraki, Zaharoula Lyristi, Filippos Koinis, Eleni Lagoudaki, Anastasios Koutsopoulos, Vassilis Georgoulias, Eleni-Kyriaki Vetsika
Published 2019-06-01
Article -
9
Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer. by Sofia Agelaki, Antonia Kalykaki, Harris Markomanolaki, Maria A Papadaki, Galatea Kallergi, Dora Hatzidaki, Kostas Kalbakis, Dimitrios Mavroudis, Vassilis Georgoulias
Published 2015-01-01
Article -
10
ES-SCLC Patients with PD-L1<sup>+</sup> CTCs and High Percentages of CD8<sup>+</sup>PD-1<sup>+</sup>T Cells in Circulation Benefit from Front-Line Immunotherapy Treatment by Anastasia Xagara, Argyro Roumeliotou, Alexandros Kokkalis, Konstantinos Tsapakidis, Dimitris Papakonstantinou, Vassilis Papadopoulos, Ioannis Samaras, Evagelia Chantzara, Galatea Kallergi, Athanasios Kotsakis
Published 2024-01-01
Article -
11
Functional Analysis of Viable Circulating Tumor Cells from Triple-Negative Breast Cancer Patients Using TetherChip Technology by Vasileios Vardas, Julia A. Ju, Athina Christopoulou, Anastasia Xagara, Vassilis Georgoulias, Athanasios Kotsakis, Catherine Alix-Panabières, Stuart S. Martin, Galatea Kallergi
Published 2023-07-01
Article -
12
-
13
The prognostic value of JUNB-positive CTCs in metastatic breast cancer: from bioinformatics to phenotypic characterization by Galatea Kallergi, Vasileia Tsintari, Stelios Sfakianakis, Ekaterini Bei, Eleni Lagoudaki, Anastasios Koutsopoulos, Nefeli Zacharopoulou, Saad Alkahtani, Saud Alarifi, Christos Stournaras, Michalis Zervakis, Vassilis Georgoulias
Published 2019-08-01
Article -
14
Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer by Galatea Kallergi, Eleni-Kyriaki Vetsika, Despoina Aggouraki, Eleni Lagoudaki, Anastasios Koutsopoulos, Filippos Koinis, Panagiotis Katsarlinos, Maria Trypaki, Ippokratis Messaritakis, Christos Stournaras, Vassilis Georgoulias, Athanasios Kotsakis
Published 2018-01-01
Article -
15
CXCR4 and JUNB double-positive disseminated tumor cells are detected frequently in breast cancer patients at primary diagnosis by Galatea Kallergi, Oliver Hoffmann, Ann-Kathrin Bittner, Lina Papadimitriou, Spyridoula D. Katsarou, Nefeli Zacharopoulou, Michalis Zervakis, Stelios Sfakianakis, Christos Stournaras, Vassilis Georgoulias, Rainer Kimmig, Sabine Kasimir-Bauer
Published 2020-04-01
Article -
16
A Comparison of Three Methods for the Detection of Circulating Tumor Cells in Patients with Early and Metastatic Breast Cancer by Eleni Politaki, Sofia Agelaki, Stella Apostolaki, Dora Hatzidaki, Areti Strati, Filippos Koinis, Maria Perraki, Georgia Saloustrou, Giannis Stoupis, Galatea Kallergi, Maria Spiliotaki, Tereza Skaltsi, Evi Lianidou, Vassilis Georgoulias, Dimitrios Mavroudis
Published 2017-11-01
Article -
17
Comprehensive Analysis of CXCR4, JUNB, and PD-L1 Expression in Circulating Tumor Cells (CTCs) from Prostate Cancer Patients by Argyro Roumeliotou, Areti Strati, Foteini Chamchougia, Anastasia Xagara, Victoria Tserpeli, Stavroula Smilkou, Elina Lagopodi, Athina Christopoulou, Emmanouil Kontopodis, Ioannis Drositis, Nikolaos Androulakis, Vassilis Georgoulias, Filippos Koinis, Athanasios Kotsakis, Evi Lianidou, Galatea Kallergi
Published 2024-05-01
Article -
18
Istaroxime Inhibits Motility and Down-Regulates Orai1 Expression, SOCE and FAK Phosphorylation in Prostate Cancer Cells by Matias Julian Stagno, Nefeli Zacharopoulou, Jonas Bochem, Anna Tsapara, Lisann Pelzl, Tamer al-Maghout, Galatea Kallergi, Saad Alkahtani, Konstantinos Alevizopoulos, Konstantinos Dimas, Theodora Calogeropoulou, Steven W. Warmann, Florian Lang, Evi Schmid, Christos Stournaras
Published 2017-07-01
Article